A study in the British medical journal, The Lancet, finds the Gardasil rival drug for human papillomavirus, Cervarix is effective against five viruses, two most common virus types that cause HPV or human papillomavirus as well as three of the next most common cervical cancer causers. The study was funded by the vaccine maker, GlaxoSmithKline.